{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:04:57Z","timestamp":1784297097469,"version":"3.55.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Instrumental variable (IV) analysis provides an alternative set of identification assumptions in the presence of uncontrolled confounding when attempting to estimate causal effects. Our objective was to evaluate the suitability of measures of prescriber preference and calendar time as potential IVs to evaluate the comparative effectiveness of buprenorphine\/naloxone versus methadone for treatment of opioid use disorder (OUD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using linked population-level health administrative data, we constructed five IVs: prescribing preference at the individual, facility, and region levels (continuous and categorical variables), calendar time, and a binary prescriber\u2019s preference IV in analyzing the treatment assignment\u2013treatment discontinuation association using both incident-user and prevalent-new-user designs. Using published guidelines, we assessed and compared each IV according to the four assumptions for IVs, employing both empirical assessment and content expertise. We evaluated the robustness of results using sensitivity analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The study sample included 35,904 incident users (43.3% on buprenorphine\/naloxone) initiated on opioid agonist treatment by 1585 prescribers during the study period. While all candidate IVs were strong (A1) according to conventional criteria, by expert opinion, we found no evidence against assumptions of exclusion (A2), independence (A3), monotonicity (A4a), and homogeneity (A4b) for prescribing preference-based IV. Some criteria were violated for the calendar time-based IV. We determined that preference in provider-level prescribing, measured on a continuous scale, was the most suitable IV for comparative effectiveness of buprenorphine\/naloxone and methadone for the treatment of OUD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our results suggest that prescriber\u2019s preference measures are suitable IVs in comparative effectiveness studies of treatment for OUD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001697","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:01:01Z","timestamp":1706637661000},"page":"218-231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine\/Naloxone or Methadone for the Treatment of Opioid Use Disorder"],"prefix":"10.1097","volume":"35","author":[{"given":"Fahmida","family":"Homayra","sequence":"first","affiliation":[{"name":"Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Enns","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Min","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kurz","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Emergency Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Greenland","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gustafson","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ehsanul","family":"Karim","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[{"name":"Addiction Medicine Section, Department of Medicine, School of Medicine, Oregon Health and Science University, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Loughin","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"MacLure","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"McCandless","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert William","family":"Platt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Schnepel","sequence":"additional","affiliation":[{"name":"Department of Economics, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shigeoka","sequence":"additional","affiliation":[{"name":"Department of Economics, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[{"name":"Department of Public Health, Health Services Research, and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria"},{"name":"Department of Health Policy and Management, Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, MA"},{"name":"Department of Radiology, Program on Cardiovascular Research, Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Socias","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada"},{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1257\/app.20210048","article-title":"Pathways into opioid addiction: evidence from practice variation in emergency departments.","volume":"14","author":"Euchmeyer","year":"2022","journal-title":"Am Econ J Appl Econ"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"107798","DOI":"10.1016\/j.drugalcdep.2019.107798","article-title":"Determinants of selection into buprenorphine\/naloxone among people initiating opioid agonist treatment in British Columbia.","volume":"207","author":"Homayra","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2005.05.002","article-title":"Buprenorphine diffusion: the attitudes of substance abuse treatment counselors.","volume":"29","author":"Knudsen","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/pds.4757","article-title":"A theoretical exploration of therapeutic monomania as a physician-based instrumental variable.","volume":"29","author":"Potter","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/EDE.0b013e31828abafb","article-title":"Issues in the reporting and conduct of instrumental variable studies: a systematic review.","volume":"24","author":"Davies","year":"2013","journal-title":"Epidemiology"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12561-011-9033-6","article-title":"Estimating decision-relevant comparative effects using instrumental variables.","volume":"3","author":"Basu","year":"2011","journal-title":"Stat Biosci"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"e036102","DOI":"10.1136\/bmjopen-2019-036102","article-title":"Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.","volume":"10","author":"Piske","year":"2020","journal-title":"BMJ Open"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.","volume":"368","author":"Pearce","year":"2020","journal-title":"BMJ"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.ede.0000222409.00878.37","article-title":"Instruments for causal inference: an epidemiologist\u2019s dream?","volume":"17","author":"Hern\u00e1n","year":"2006","journal-title":"Epidemiology"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ije\/29.4.722","article-title":"An introduction to instrumental variables for epidemiologists.","volume":"29","author":"Greenland","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/EDE.0b013e31828d0590","article-title":"Commentary: how to report instrumental variable analyses (suggestions welcome).","volume":"24","author":"Swanson","year":"2013","journal-title":"Epidemiology"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/EDE.0000000000000279","article-title":"Definition and evaluation of the monotonicity condition for preference-based instruments.","volume":"26","author":"Swanson","year":"2015","journal-title":"Epidemiology"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ede.0000193606.58671.c5","article-title":"Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.","volume":"17","author":"Brookhart","year":"2006","journal-title":"Epidemiology"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jclinepi.2021.06.006","article-title":"Preference-based instrumental variables in health research rely on important and underreported assumptions: a systematic review.","volume":"139","author":"Widding-Havneraas","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jclinepi.2010.09.006","article-title":"Use of instrumental variable in prescription drug research with observational data: a systematic review.","volume":"64","author":"Chen","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/aje\/kwr323","article-title":"Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions.","volume":"175","author":"Glymour","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pds.1908","article-title":"Instrumental variable methods in comparative safety and effectiveness research.","volume":"19","author":"Brookhart","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/aje\/kwu284","article-title":"Selecting on treatment: a pervasive form of bias in instrumental variable analyses.","volume":"181","author":"Swanson","year":"2015","journal-title":"Am J Epidemiol"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/aje\/kwp002","article-title":"Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable.","volume":"169","author":"Cain","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: a national clinical practice guideline.","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/aje\/kwr057","article-title":"Reducing the variance of the prescribing preference-based instrumental variable estimates of the treatment effect.","volume":"174","author":"Abrahamowicz","year":"2011","journal-title":"Am J Epidemiol"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jclinepi.2011.06.012","article-title":"Treatment effect estimates varied depending on the definition of the provider prescribing preference-based instrumental variables.","volume":"65","author":"Ionescu-Ittu","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"R37-20250801","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/ije\/dyaa150","article-title":"Cohort profile: the provincial substance use disorder cohort in British Columbia, Canada.","volume":"49","author":"Homayra","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R38-20250801","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jclinepi.2013.06.008","article-title":"Physicians\u2019 prescribing preferences were a potential instrument for patients\u2019 actual prescriptions of antidepressants.","volume":"66","author":"Davies","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R39-20250801","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jclinepi.2008.12.006","article-title":"Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.","volume":"62","author":"Rassen","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R40-20250801","doi-asserted-by":"crossref","first-page":"e036102","DOI":"10.1136\/bmjopen-2019-036102","article-title":"Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.","volume":"10","author":"Piske","year":"2020","journal-title":"BMJ Open"},{"key":"R41-20250801","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection.","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"R42-20250801","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1257\/aer.20161503","article-title":"The effects of pretrial detention on conviction, future crime, and employment: evidence from randomly assigned judges.","volume":"108","author":"Dobbie","year":"2018","journal-title":"Amer Econ Rev"},{"key":"R44-20250801","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/rssb.12262","article-title":"Bounded, efficient and multiply robust estimation of average treatment effects using instrumental variables.","volume":"80","author":"Wang","year":"2018","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"R45-20250801","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2307\/2171753","article-title":"Instrumental variables regression with weak instruments.","volume":"65","author":"Staiger","year":"1997","journal-title":"Econometrica"},{"key":"R49-20250801","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/01621459.2018.1434530","article-title":"Partial identification of the average treatment effect using instrumental variables: review of methods for binary instruments, treatments, and outcomes.","volume":"113","author":"Swanson","year":"2018","journal-title":"J Am Stat Assoc"},{"key":"R50-20250801","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/EDE.0000000000001126","article-title":"Application of the instrumental inequalities to a Mendelian randomization study with multiple proposed instruments.","volume":"31","author":"Diemer","year":"2020","journal-title":"Epidemiology"},{"key":"R52-20250801","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/EDE.0000000000000287","article-title":"Toward a clearer portrayal of confounding bias in instrumental variable applications.","volume":"26","author":"Jackson","year":"2015","journal-title":"Epidemiology"},{"key":"R53-20250801","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/ije\/dyx014","article-title":"How to compare instrumental variable and conventional regression analyses using negative controls and bias plots.","volume":"46","author":"Davies","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R54-20250801","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s40471-018-0152-1","article-title":"Understanding the assumptions underlying instrumental variable analyses: a brief review of falsification strategies and related tools.","volume":"5","author":"Labrecque","year":"2018","journal-title":"Curr Epidemiol Rep"},{"key":"R55-20250801","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1214\/14-STS491","article-title":"Think globally, act globally: an epidemiologist\u2019s perspective on instrumental variable estimation.","volume":"29","author":"Swanson","year":"2014","journal-title":"Stat Sci"},{"key":"R56-20250801","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hec.3647","article-title":"2SLS versus 2SRI: appropriate methods for rare outcomes and\/or rare exposures.","volume":"27","author":"Basu","year":"2018","journal-title":"Health Econ"},{"key":"R60-20250801","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/pds.1757","article-title":"Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study.","volume":"18","author":"Ionescu-Ittu","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R61-20250801","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1524-4733.2007.00234.x","article-title":"Estimating the effect of treatment rate changes when treatment benefits are heterogeneous: antibiotics and otitis media.","volume":"11","author":"Park","year":"2008","journal-title":"Value Health"},{"key":"R62-20250801","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1097\/MLR.0b013e318070c057","article-title":"Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects?","volume":"45","author":"Brookhart","year":"2007","journal-title":"Med Care"},{"key":"R63-20250801","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/add.15737","article-title":"Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada.","volume":"117","author":"Kurz","year":"2022","journal-title":"Addiction"},{"key":"R64-20250801","doi-asserted-by":"crossref","first-page":"108799","DOI":"10.1016\/j.drugalcdep.2021.108799","article-title":"Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012-2018.","volume":"225","author":"Krebs","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"R65-20250801","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12874-021-01449-w","article-title":"Instrumental variable estimation for a time-varying treatment and a time-to-event outcome via structural nested cumulative failure time models.","volume":"21","author":"Shi","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"R66-20250801","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1740774511420743","article-title":"Beyond the intention-to-treat in comparative effectiveness research.","volume":"9","author":"Hern\u00e1n","year":"2012","journal-title":"Clin Trials"},{"key":"R68-20250801","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.EDE.0000042804.12056.6C","article-title":"Quantifying biases in causal models: classical confounding vs collider-stratification bias.","volume":"14","author":"Greenland","year":"2003","journal-title":"Epidemiology"},{"key":"R69-20250801","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s11606-019-05023-5","article-title":"Emergency physician opioid prescribing and risk of long-term use in the Veterans Health Administration: an observational analysis.","volume":"34","author":"Barnett","year":"2019","journal-title":"J Gen Intern Med"},{"key":"R70-20250801","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/ndt\/gfn592","article-title":"The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the dialysis outcomes and practice patterns study.","volume":"24","author":"Tentori","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R73-20250801","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jama.297.3.278","article-title":"Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.","volume":"297","author":"Stukel","year":"2007","journal-title":"JAMA"},{"key":"R74-20250801","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.300.2.173","article-title":"Survival following primary androgen deprivation therapy among men with localized prostate cancer.","volume":"300","author":"Lu-Yao","year":"2008","journal-title":"JAMA"},{"key":"R75-20250801","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.1994.03520110039026","article-title":"Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.","volume":"272","author":"McClellan","year":"1994","journal-title":"JAMA"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:05:02Z","timestamp":1754060702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001697","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}